During the past decade, Eastchester Center for Cancer Care conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastchester Center for Cancer Care" #1 sponsor was "Cornerstone Pharmaceuticals" with 4 trials, followed by "Novartis Pharmaceuticals" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Agendia" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastchester Center for Cancer Care" #1 collaborator was "AdventHealth" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Morton Plant Mease Health Care" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Eastchester Center for Cancer Care" are "Breast Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Eastchester Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Eastchester Center for Cancer Care" are "Drug" (20 trials), "Other" (6 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CPI-613" (4 trials), "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Alectinib" (2 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eastchester Center for Cancer Care" are 19 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Eastchester Center for Cancer Care". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Eastchester Center for Cancer Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eastchester Center for Cancer Care, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".